| Ranking |
Company |
Total Points |
| 1 |
AbbVie Inc. |
4’359 |
| 2 |
UCB BioPharma SRL |
3’378 |
| 3 |
Pfizer Inc. |
2’949 |
| 4 |
Janssen Pharmaceutica NV |
2’896 |
| 5 |
Novartis Pharma AG |
1’915 |
| 6 |
Eli Lilly and Company |
1’637 |
| 7 |
AstraZeneca UK Ltd. |
1’414 |
| 8 |
GlaxoSmithKline Research and Development Ltd. |
1’245 |
| 9 |
Bristol-Myers Squibb |
1’220 |
| 10 |
Galapagos NV |
1’194 |
| 11 |
medac GmbH |
1'175 |
| 12 |
Boehringer Ingelheim International GmbH |
924 |
| 13 |
Amgen (Europe) GmbH |
888 |
| 14 |
F. Hoffmann-La Roche Ltd. |
552 |
| 15 |
Vifor Fresenius Medical Care Renal Pharma Ltd. |
537 |
| 16 |
IBSA Institut Biochimique SA |
513 |
| 17 |
Fresenius Kabi SwissBioSim |
494 |
| 18 |
Celltrion Healthcare Co. Ltd. |
415 |
| 19 |
Otsuka Pharmaceutical Europe Ltd. |
120 |
| 20 |
Biogen International GmbH |
115 |
| 21 |
Merck Healthcare KGaA |
78 |
| 22 |
Gilead Sciences Europe Ltd. |
47 |
|
EULAR 2024 Corporate Members Attribution Process
Application for Corporate Membership of EULAR
|
|
|
